Veeva Systems is set to launch its Veeva AI Agents starting December 2025, introducing agentic AI capabilities across its Vault Platform and various Veeva applications. These AI agents are designed specifically for the life sciences industry, covering areas such as commercial, clinical, regulatory, safety, quality, and medical functions. The rollout will be phased, beginning with commercial applications in December 2025 and extending to R&D, quality, clinical operations, regulatory, medical, and clinical data applications through 2026.
Veeva AI Agents debut December 2025 with expansions across clinical and regulatory areas throughout 2026.
Agents are embedded in the Veeva Vault Platform with secure, direct access to application data, documents, and workflows.
Designed for high-impact, industry-specific use cases with application-centric prompts and safeguards.
Utilize LLMs from Anthropic and Amazon, hosted on Amazon Bedrock; support custom models via Amazon Bedrock or Microsoft Azure AI Foundry.
Customers can configure, extend, or build custom AI agents tailored to unique business requirements.
Usage-based pricing model facilitates scalability and adoption across enterprises.
Veeva AI Agents are developed to deeply understand the context of Veeva applications, enabling sophisticated automation and intelligent assistance tailored to workflows within the life sciences sector. These agents assist in automating documentation, regulatory submissions, safety and quality monitoring, clinical trial operations, and commercial tasks to enhance productivity and compliance.
Embedded within the Veeva Vault Platform, AI Agents provide robust security features and allow organizations to customize AI behavior according to their governance standards. Customers can leverage prebuilt agents or develop bespoke AI assistants using the platform, promoting innovation and operational efficiency.
CEO Peter Gassner emphasizes that AI will fundamentally transform drug development and treatment decisions, accelerating the delivery of better medicines to patients worldwide through enhanced innovation and productivity driven by Veeva AI.
Veeva Systems delivers an industry cloud for life sciences software, data, and consulting, serving over 1,500 customers globally from large pharmaceutical firms to emerging biotechs. As a Public Benefit Corporation, Veeva balances customer, employee, shareholder, and industry interests.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.